Multiple myeloma: signaling pathways and targeted therapy
Q Lu, D Yang, H Li, T Niu, A Tong - Molecular Biomedicine, 2024 - Springer
Multiple myeloma (MM) is the second most common hematological malignancy of plasma
cells, characterized by osteolytic bone lesions, anemia, hypercalcemia, renal failure, and the …
cells, characterized by osteolytic bone lesions, anemia, hypercalcemia, renal failure, and the …
Associated of Variable Number Tandem Repeat (VNTR) Polymorphism in IL 4 with Susceptibility to Breast Cancer in Iraqi Women
NI Oun, MH Salih - Journal for Research in Applied Sciences and …, 2024 - jrasb.com
Background: Breast cancer (BC) is common disease in the worldwide. Furthermore genetic
mutations are known to enhance BC risk. The aim of this research is to examine correlation …
mutations are known to enhance BC risk. The aim of this research is to examine correlation …